Unicycive Therapeutics Inc.

09/03/2024 | Press release | Distributed by Public on 09/03/2024 05:06

Unicycive Therapeutics Announces Submission of the New Drug Application (NDA) to the U.S. FDA for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in[...]